SCHEMBL4742558

SCHEMBL4742558

CC(C)(C)OC(=O)CC(NC(=O)c1cnc2c(C(F)(F)F)cccc2c1N1CCN(C(=O)OC(C)(C)C)CC1)C(O)CF

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.44
TP53 P04637 1/20 0.44
MAPK1 P28482 1/20 0.44
RECQL P46063 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PTPN11 Q06124 1/20 0.38
SOS1 Q07889 1/20 0.37
ACHE P22303 2/20 0.36
BACE1 P56817 1/20 0.35
MET P08581 1/20 0.35
MAPT P10636 3/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
GLA P06280 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CKS1B P61024 1/20 0.34
SKP1 P63208 1/20 0.34
SKP2 Q13309 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4786909 0.89 MET (0.39) USP2TP53MAPK1RECQLHSD17B10
SCHEMBL4742621 0.87 USP2 (0.45) USP2TP53MAPK1RECQLHSD17B10
SCHEMBL4742105 0.84 THRB (0.45) PTPN11METMAPTSMN1; SMN2RXFP1
SCHEMBL4743444 0.80 USP2 (0.54) USP2TP53MAPK1RECQLHSD17B10
SCHEMBL4743037 0.79 MAPT (0.40) USP2TP53MAPK1RECQLHSD17B10
SCHEMBL4785451 0.77 MAPK1 (0.72) USP2TP53MAPK1RECQLHSD17B10
SCHEMBL4743406 0.77 MET (0.39) USP2TP53MAPK1RECQLHSD17B10
SCHEMBL4743466 0.75 THRB (0.46) USP2TP53MAPK1RECQLHSD17B10
SCHEMBL4743456 0.70 MAPT (0.47) USP2TP53MAPK1RECQLHSD17B10
SCHEMBL4785479 0.70 THRB (0.42) PTPN11METMAPTLMNACKS1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008093940-A1 QUINOLINE DERIVATIVES AS CASPASE-3 INHIBITOR, PREPARATION PROCESS FOR THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 2008-08-07 WO disclosed